These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19223735)

  • 1. [Urological cancer].
    Miyanaga N; Akaza H
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):193-8. PubMed ID: 19223735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy and radiotherapy for urological cancer].
    Miyanaga N; Tsukamoto S; Hattori K; Kawai K; Shimazui T; Uchida K; Akaza H
    Gan To Kagaku Ryoho; 2002 May; 29(5):709-16. PubMed ID: 12040674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy in urologic oncology].
    Deville JL
    Prog Urol; 2011 Nov; 21(11):816-21. PubMed ID: 22032608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evidence-based medicine for urological cancer chemotherapy].
    Tsukamoto S; Miyanaga N; Kawai K; Akaza H
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):183-91. PubMed ID: 10700888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant systemic therapy for urological malignancies.
    Sonpavde G; Sternberg CN
    BJU Int; 2010 Jul; 106(1):6-22. PubMed ID: 20553475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel agents for muscle-invasive and advanced urothelial cancer.
    Sonpavde G; Ross R; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Lerner SP; Sternberg CN
    BJU Int; 2008 Apr; 101(8):937-43. PubMed ID: 18005203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy in urological tumors.
    Stoter G; Smith PH; Williams G
    Prog Clin Biol Res; 1984; 153():587-93. PubMed ID: 6089230
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for advanced prostate cancer: docetaxel and beyond.
    Dreicer R
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):935-46, x. PubMed ID: 16861124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metastatic urothelial cancer: opportunities for drug discovery and development.
    Sonpavde G; Sternberg CN
    BJU Int; 2008 Nov; 102(9 Pt B):1354-60. PubMed ID: 19035904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
    Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving role of chemotherapy in advanced urothelial cancer.
    Calabrò F; Sternberg CN
    Curr Opin Support Palliat Care; 2007 Oct; 1(3):180-6. PubMed ID: 18685360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current optimal chemotherapy for advanced urothelial cancer.
    Sonpavde G; Galsky MD; Hutson TE
    Expert Rev Anticancer Ther; 2008 Jan; 8(1):51-61. PubMed ID: 18095883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi FA; Kassouf W
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):747-52. PubMed ID: 19496711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy for urological cancer : usefulness and feasibility of current protocols].
    Hara I; Motoo Y
    Hinyokika Kiyo; 2011 Mar; 57(3):151-2. PubMed ID: 21586888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What are waiting for chemotherapy in urology (author's transl)].
    Benoit G; Boccon-Gibod L; Debre B; Steg A
    Sem Hop; 1981 Jun 18-25; 57(25-28):1228-37. PubMed ID: 6266046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapies for non-metastatic prostate cancer: review of the literature.
    Jereczek-Fossa BA; Curigliano G; Orecchia R
    Onkologie; 2009 Jun; 32(6):359-63. PubMed ID: 19521126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy indications in the treatment of metastases from urological malignancies].
    Théodore C
    Prog Urol; 2008 Nov; 18 Suppl 7():S219-22. PubMed ID: 19070795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular therapy in urologic oncology.
    Froehner M; Hakenberg OW; Wirth MP
    Urol Int; 2007; 79(1):1-7. PubMed ID: 17627159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer.
    Gazzaniga P; Gradilone A; de Berardinis E; Sciarra A; Cristini C; Naso G; di Silverio F; Frati L; Aglianò AM
    BJU Int; 2009 Jul; 104(2):184-8. PubMed ID: 19154503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.